Market Research Blog – Page 14466 – New Product Development

Aquaculture Therapeutics Market Important Changes in Industry Dynamics during 2016-2026

Aquaculture Therapeutics Market Overview

The Farming or the culturing of aquatic animals like the fishes, algae, mollusks, crustaceans, aquatic plants and other aquatic organisms in different types of water is termed as Aquaculture. The cultivation process involves nurturing of these aquatic organism in the controlled condition either in fresh or in salt water. Later on these aquatic organisms are then harvested to be served as the source of nutrition or to be used for many other purposes. The aquatic animals are very sensitive and are prone to various epidemic diseases. Other factors affecting the aquatic cultured animals are Pathogens (e.g. bacteria, viruses, fungi and parasites) exist in all natural water bodies. At the same time crowded culture environment makes the causes high risk for infection and makes the fishes nervous. Crowding also results in fish knocking eventually leading to surface wounds which is a cause for inaction. These can be cured using several FDA approved antibiotics and other medicines. Apart from diseases medicines are used to improve the wellbeing of the fishes in the aquaculture. The list of drugs includes chorionic gonadotropin, formalin solution, florfenicol, oxytetracycline, tricaine methane sulfonate, hydrogen peroxide, sulfadimethoxine/ormetoprim combination, acetic acid, calcium chloride, calcium oxide, carbon dioxide gas, fuller’s earth, garlic (whole form), ice, magnesium sulfate, papain, potassium chloride, povidone iodine, sodium bicarbonate, sodium chloride, sodium sulfite, thiamine hydrochloride, urea and tannic acid. The above mentioned drugs take care of the aquatic animals fighting with several diseases which are not only harmful to the aquatic animals but are also harmful to the consumer. There are two different categories of diseases which affect the aquatic population viz. diseases due to pathogens which are indigenous to the local environment and exotic pathogens.

Aquaculture Therapeutics Market: Drivers and Restraints

A lot of advances are taking place in the aquaculture therapeutics as there are several diseases which are affecting the animals cultured in the aquaculture. There are several diseases which are driving the aquaculture therapeutics market. Mostly the diseases are dependent on hygiene conditions which are to be maintained. Advances in aquaculture therapeutics, and growing demand for the more effective aquaculture therapeutic drugs are the factors expected to drive the growth of aquaculture therapeutics market. More over the demand for aquaculture is growing day by day due to the decreasing number of the oceanic fishes and increasing consumption of the fishes at a global level.

Aquaculture therapeutics market: Overview

Despite the long tradition of practicing aquaculture in several countries it is still a growing and a business with great scope. The requirement of aquaculture therapeutics is increasing day by day as more and more countries have stared adopting aquaculture which is cheaper source of protein. As the fishes or the animals are consumed by the human FDA has set up certain regulatory guidelines for the drugs to be administered to the fishes in aquaculture. They are categorized as conditionally approved animal drugs and indexed animal drugs. Depending upon environmental and diseased conditions these drugs are used in the aquatic fishes.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2463

Aquaculture therapeutics market: Regional Overview

Region wise, the global Aquaculture therapeutics market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. China is the leading in the aquaculture market which contributes around 61% of the global aquaculture market which is followed by Indonesia and India.

Aquaculture therapeutics market: Key Players

Some of the key players in global Aquaculture therapeutics market are TunaTech GmbH, ViAqua Therapeutics Ltd, Alpharma, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-2463

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Aquaculture Therapeutics Market: Segmentation

The global Aquaculture therapeutics market has been classified on the basis of product type, end user and geography.

Based on product type, the global Aquaculture therapeutics market is divided into following:

Chorionic Gonadotropin
Formalin Solution
Florfenicol
Oxytetracycline
Tricaine Methane Sulfonate
Hydrogen Peroxide
Sulfadimethoxine/Ormetoprim combination

Based on the end user type, the global aquaculture therapeutics market is divided into following:

Veterinary Pharmacies
E commerce
Veterinary Clinics
Veterinary Hospitals

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-2463

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Continuous Glucose Monitoring Systems Market Key Players – Abbott, Medtronic, Dexcom, Animas, Roche, Bayer, Glysens and Ypsomed

According to a recent market report published by Future Market Insights, titled “Continuous Glucose Monitoring Systems Market – Global Industry Analysis and Opportunity Assessment, 2015–2020”, the global continuous glucose monitoring systems market was valued at US$ 445.8 Mn in 2015 and is expected to register a CAGR of 12.1% from 2015 to 2020.

Continuous glucose monitoring systems are adopted by many end-users including household, and hospitals and diagnostics centers. There is an increase in the usage of continuous glucose monitoring systems components in hospitals and diagnostic centers due to an increase in the demand for sensor.

Currently, companies are focusing on continuous development and the introduction of innovative continuous glucose monitoring system devices to receive FDA approval for various brands, which has led to high competitiveness in the market. Scientists are conducting research and testing continuous glucose monitoring systems to provide effective systems and aid better management of diabetes. Thus, there is scope for the introduction of new and advanced continuous glucose monitoring systems in the near future. Market players operating in the continuous glucose monitoring systems market are focused towards the integration of advanced technologies in products in order to offer variations and trends in the type of blood glucose level display.

On the other hand, the high cost of continuous glucose monitoring systems acts as a restrain for the growth of the market as treatment with continuous glucose monitoring systems costs around US$ 4,930 to US$ 7,120 per person. This makes it unaffordable for a large portion of the global population. For instance, glucose monitors used in continuous glucose monitoring systems cost between US$ 1,000 and US$ 1,400, while sensors cost between US$ 35 and US$ 100 apiece. Besides this, sensors have a very short lifespan – around 3 to 7 days – since they are prone to biofouling, which affects the accuracy of the continuous glucose monitoring systems.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-694

Due to the lack of accuracy in the readings of glucose levels in critical cases, continuous glucose monitors are incapable of preventing severe hypoglycemia stage, in which the glucose level in the body is extremely low. For instance, continuous glucose monitoring systems are up to 21% less accurate when compared with actual plasma glucose values and this percentage increases when there is a rapid rise and fall in plasma glucose. According to the results of studies, it is estimated that the probable reason behind this problem is the real-time performance delay of continuous glucose monitoring systems.

The global continuous glucose monitoring systems market has been categorized on the basis of component into transmitter & monitor, sensor and insulin pump. On the basis of end-use, the continuous glucose monitoring systems market has segmented into household and hospitals and diagnostics centers. In terms of revenue, the household segment dominated the global continuous glucose monitoring systems market. Hospital and diagnostics centers segments are anticipated to expand at the fastest CAGRs over the forecast period.

This continuous glucose monitoring systems report also covers trends that drive each segment and offers analysis & insights regarding the potential of the continuous glucose monitoring systems market in regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East & Africa, and Japan. Among these regions, the APEJ continuous glucose monitoring systems market is projected to exhibit relatively high growth in the global continuous glucose monitoring systems market with a CAGR of 16% over the forecast period. Revenue from the continuous glucose monitoring systems market in APEJ accounted for over 7% of the global continuous glucose monitoring systems market revenue in 2015. Providers of continuous glucose monitoring systems can focus on expanding across several countries in APEJ such as India and China.

Some of the key competitors in the continuous glucose monitoring systems market include Abbott, Medtronic, Dexcom, Animas, Roche, Bayer, Glysens and Ypsomed. These key players are constantly focusing on product innovation and geographical expansion to sustain their market presence and increase revenue generation by developing various types of devices and delivering outstanding offerings to several end-users.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-694

Key Segments Covered in the continuous glucose monitoring system MarketComponent

Transmitter & monitor
Sensor
Insulin Pump

End-user

Household, and hospitals
Diagnostics Centres

Key Regions Covered

North America
Latin America
Western Europe
Eastern Europe
Japan
APEJ
Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-694

First Aid Market is projected to exhibit a CAGR of 6.3% during the forecast period

Future Market Insights (FMI), in its latest report titled, “China First Aid Market Assessment and Opportunity 2014 – 2020”, projects the China first aid market to exhibit a CAGR of 6.3% between 2015 and 2020. Adoption of aggressive promotional campaigns are key factors driving growth of the market.

The report is focused on basic first aid products such as adhesive bandages, disinfectants and gauzes. Though the basic wound care segment in China accounts for miniscule share of the overall wound care market in China, it is expected to witness significant growth over the next few years. Increasing awareness about non-traditional first-aid products among consumers in Tier 2 and Tier 3 cities is the prime driving factor for the market in the region.

As of 2014, basic first aid products accounted for less than 20% share of the overall wound care market in China. Strategies such as innovative product packaging along with aggressive market campaigning has led to surge in demand for these products in China. Government emphasis on healthcare policies, liberalization of policies related to distribution of licenses and FDI influx are other key driving factors of the first aid market in China. On the flipside, low healthcare expenditure and higher preference for Chinese traditional medicines among consumers is a major restraint for non-traditional wound care product manufacturers.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-cn-659

First-Aid Market

The report analyses the China first aid market in terms of sales revenue (US$ Mn) by product, cities and by retail sales channel and provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast.

On the basis of city, the China first-aid market has been segmented into Tier 1, Tier 2 and Tier 3 Cities. Among Tier 1 cities, Shanghai offers good market opportunities for first-aid products manufacturers. It is anticipated to generate 1.4X higher sales revenue by the end of the forecast period as compared to that in 2014. Disinfectant products are anticipated to account for over half of the sales revenue in Tier 1 cities, followed by gauzes and bandages respectively. Tier 2 cities are expected to generate 1.3X higher revenue than Tier 3 cities by the end of 2020.

Among retail sales channels, drugstores and pharmacies are key channels for sales of adhesive bandages. Hospitals are the key channel for sales of gauzes. Hospitals account for major share of retail sales in Tier 3 cities in China. Though drugstores, pharmacies and hospitals are key retail sales channels for adhesive bandages and gauzes, modern retail sales channel are the most preferred mode for sales of disinfectants. Hypermarkets and supermarkets account for over 60% share of retail sales of disinfectants.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-cn-659

By product type, the China first aid market has been segmented into adhesive bandages, gauzes and disinfectants (antiseptics). While disinfectants are projected to be the largest market segment throughout the forecast period, its presence is limited to Tier 1 and Tier 2 cities in China. The disinfectant products segment is anticipated to register a CAGR of 7.5% between 2014 and 2020. Reckitt Benckiser and Walch are key players in this product segment. Organized players account for significant market share in the disinfectants products segment. Among products, gauzes (woven and non-woven) covers significant market in Tier 3 cities in China. Sales revenue of adhesive bandages is further segmented into butterfly stiches, transdermal bandages and special bandages. Transdermal bandages account for significant market share in the adhesive bandages segment.

Key players in the China first aid market include Johnson and Johnson, Winner Medical Group Co., Reckitt Benckiser, Yunnan Baiyao, 3M Company, Nepstar Drugstore, 7-Eleven, Beijing Hualian Group and A.S Watson Group.

Key SegmentBy Product Type

Bandages
Gauzes
Disinfectants

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-cn-659

Dimer Acid-Based (DAB) Polyamide Resins Market 2022 | Scope of Current and Future Industry 2025

Dimer acids which are also known as dimerized fatty acids belong to the group of dicarboxylic acids. Dimer acids are viscous fluids that are transparent and non-toxic in nature. Dimer acids are manufactured by dimerizing unsaturated fatty acids that are obtained from oleic acid, canola oil, tallow, cottonseed, tall oil and rapeseed among others. Dimer acids are widely used to synthesize polyamide resins and hot melt adhesives. Dimer acid-based polyamide resins have varied properties which makes them either reactive or non-reactive in nature. Reactive polyamides are primarily used as curing agents for epoxy resins that are generally used in the manufacturing of adhesives and surface coatings. On the other hand, the non reactive polyamides are predominantly used in the manufacturing of printing inks and hot-melt adhesives. Dimer acid-based polyamide resins exhibit physical properties such as heat resistance, cold resistance, film flexibility, fast curing, oil resistance, excellent adhesion and good compatibility among others. Dimer acid-based polyamide resins are widely used as decorative coatings, fabrics, interlining, shoe stretch, fold plastic and Baotou glue.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-337

Growing economies of developing countries coupled with rising disposable income has boosted the overall demand for residential properties which in turn is expected to augment the overall growth of construction industry. Construction industry is the major application of adhesives and surface coatings. Thus, the growing demand for adhesives and surface coatings from various end-use industries such as construction is expected to drive the overall dimer acid-based polyamide resins market. Dimer acid-based polyamide resins are also mainly consumed in the manufacturing of printing inks. Dimer acid-based polyamide resins exhibit improved freeze thaw characteristics to the printing ink compositions. Thus, the use of dimer acid-based polyamide resins plays a crucial role in improving the overall quality of the printing inks. Thus, growing demand for printing ink is expected to augment the overall growth of dimer acid-based polyamide resins market.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-337

China is the major consumer of dimer acid-based polyamide resins owing to the presence of huge demand for adhesives and surface coatings from construction and automobile applications. North America is expected to be the next largest consumer of dimer acid-based polyamide resins owing to the presence of huge demand for printing inks in the region. The demand for DAB polyamide resins is expected to grow rapidly in Europe owing to the huge demand for surface coatings from the automobile industry present in the region. Rest of Asia Pacific is anticipated to experience huge demand for dimer acid-based polyamide resins owing to the growing construction industry in countries such as India, Japan and Korea present in the region. Rest of the World is expected to exhibit sluggish growth in the demand for dimer acid-based polyamide resins market in the near future.

Arizona Chemical, Anqing Hongyu Chemical Co., Ltd., The Dow Chemical Company, Jinan Tongfa Resin Co., Ltd. and RITEKS are some of the major participants of the dimer acid-based polyamide resins market. The companies are mainly focused towards achieving economies of scale. Hence, most of the leading players are striving towards increasing their production capacities for manufacturing dimer acid-based polyamide resins market. The companies are also hugely investing in research in order to develop innovative products having superior qualities.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-337

This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and distribution channels.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size & Forecast 2015 -2025
Supply & Demand Value Chain
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Market Drivers and Restraints

Regional analysis includes

North America
- US & Canada
Latin America
- Brazil, Mexico, Others
Western Europe
- EU5
- Nordics
- Benelux
Eastern Europe
Asia Pacific
- Australia and New Zealand (ANZ)
- Greater China
- India
- ASEAN
- Rest of Asia Pacific
Japan
Middle East and Africa
- GCC Countries
- Other Middle East
- North Africa
- South Africa
- Other Africa

Dimer Acid Based Polyamide Resins Market

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth.

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

High Content Screening Market Report- Drivers and Restraints, Growth Opportunity Assessment and Forecast to 2031

The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of 2021. As per the study, the pharmaceutical and the healthcare sector will account for over 31% of demand registered in the market in 2021.

High content screening is adopted for drug discovery and development. Increasing research in search of the novel drug candidate and target identification & validation is expected to propel the adoption of high content screening over the forecast years. Besides this, continuous focus on manufacturing high quality and technologically advanced cell imaging system is expected to accelerate demand over the course of the forecast period.

However, due to COVID 19 outbreak, the research and development activities were hampered immensely. This is expected to have a negative impact on the market. Nonetheless, increasing investments by key manufacturers in the development of advanced cell imaging product is expected to boost the market in the coming years.

Key Takeaways of High Content Screening Market Study

The high content screening market will rise at register a little below 5% y-o-y growth in 2021, following a brief period of restrictions amid COVID-19
Presence of a sophisticated healthcare and pharmaceutical infrastructure is enabling the U.S. market account for over 90% of sales in North America
The U.K. will register an impressive 7.2% y-o-y growth in 2021 driven by increasing focus on research and development activities in the pharmaceutical sector
Demand registered in Germany and France is expected to rise significantly within Europe
Favorable government policies will support expansion in Japan, followed by China

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-426

“Demand for novel technologies for cell analysis and drug discovery is expected to improve the manufacturing speed, throughput, and reliability. This is expected to create growth opportunities for market players,” Says the FMI Analyst.

Who is Winning?The key manufacturers in the high content screening market are involved in several partnerships and collaboration to develop new cell imaging technology. The leading manufacturers are also making their business strategies by making collaborations with international laboratories and research institutes to develop new imaging technologies.

For instance, In December 2019, Leica Microsystems make a collaboration agreement with the European Molecular Biology Laboratory (EMBL) to develop new imaging technologies applicable in life science. With this agreement EMBL and Leica promoting new imaging technologies for cell imaging.

Valuable Insights into High Content Screening Market StudyFuture Market Insights offers actionable insights and a unique perspective on the high content screening market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product (cell imaging & analysis, consumables, Softwares, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others), and by application (primary & secondary screening, target identification & validation, toxicity studies, compound profiling and others) in seven key regions.

High-Content-Screening Market by CategoryProduct Type

Cell Imaging & Analysis
- HCS Instruments
  - High-End HCS
  - Mid End HCS
  - Low-End HCS
- Flow Cytometers
Consumables
- Microplates
- Reagents & Assay Kits
- Other Consumables
Softwares
Services

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-426

Industry

Pharmaceutical & Healthcare
Biotechnology
Educational Institutions
Independent CRO
Government Organizations
Others

Application

Primary & Secondary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Brain Tumor Treatment Market is expected to provide the lucrative growth over forecasted period

Brain Tumor Treatment Market Overview

A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor eventually compress and damage other structures in the brain. According to American Brain Tumor Association (ABTA), there are two types of brain tumors – primary and secondary. Primary tumors arises from brain tissue and secondary tumors arises from other parts of the body and spreads to brain. Gliomas are most common type of primary tumors which arises from brain’s glial tissue. Glioblastoma multifome is a fast growing and of higher grade when compared to other tumors. Advanced medications are available to treat the brain tumors. Increasing pharmaceutical R&D spending is expected to provide the lucrative growth for the global brain tumor treatment market over the forecasted period.

Brain Tumor Treatment Market: Drivers and restraints

Increasing incidence of brain tumor (Glioblastoma) is one of the leading factor driving the growth of the market globally. For instance, as per the American Society of Clinical Oncology (ASCO), brain tumor incidence rate growing at 2.6% compared to the last year. An estimated 22,850 cases diagnosed with primary cancerous tumors of the brain in the U.S. Furthermore, increasing geriatric population is also driving the brain tumor market. Increasing consumer awareness regarding the latest technological advancements in therapies, and medications are responsible for the growth of global brain tumor treatment market.

Brain Tumor Treatment Market: Overview

Increase in incidence rate of brain tumor has fuelled the demand for effective treatment. As such, global companies are spending significant portion of their revenue on R&D to develop novel medications. Many products related to novel drug delivery technologies are lined up for FDA approval. Increasing demand for advance medication to treat brain tumors is expected to fuel overall growth of the market.

Brain Tumor Treatment Market: Region-Wise Outlook

Depending upon the geographic regions brain tumor treatment market segmented into seven key regions: Those are North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1302

North America and European region is expected to dominate the global brain tumor market throughout the forecast period, owing to increasing incidences of glioblastoma coupled with technological advancements.

Though North America and Europe are expected to lead the market, Asia Pacific is anticipated to witness robust growth. Significant increase in incidence rate of brain tumors along with shifting of locus of economic activity and dynamism to this region is expected to boost the demand for drugs responsible for brain tumor treatment.

Latin America and MEA are expected to witness moderate growth during the forecast period. Companies need to capitalize their resources in emerging regions to gain market share in brain tumor treatment market.

Brain Tumor Treatment Market: Key players

Key players in the brain tumor treatment market are Genetech U.S.A, Bristol Myers Squibb, Hoffmann- La Roche, AstraZeneca plc, Pfizer, Inc., Novartis AG, Antisense Pharma, Merck & Co, Macleods Pharmaceutical Limited, Mankind Pharma, Dr. Reddys Laboratories Ltd.

Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1302

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
Eastern Europe (Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa)

Brain Tumor Treatment Market: Segmentation

Global Brain Tumor Treatment Market can be segmented as following types

By Product:

Temozolomide
Carmustine
Cisplatin
Bevacizumab
Geftinib
Erlotinib

By End user:

Hospital Pharmacies
Ambulatory Surgical Centers
Individual Pharmacies

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-1302

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Phospholipids Market Is Set to Experience Revolutionary Growth by 2031

Phospholipids are obtained from oilseed such as sunflower, rapeseed, and soy. The abundant availability of phospholipids and increasing demand in cosmetics, hair care, pharmaceutical, and nutraceutical industries will aid expansion of the market, finds Future Market Insights (FMI) in a new study. According to the report, the phospholipids market will reach US$ 2.85 Bn in 2021.

The multi-functional nature of phospholipids is expected to fuel demand in various end-use industries. Its emulsifying property is driving food and industrial application. Increasing consumption of bakery products like breads, pastries and cupcakes is will fuel the demand for phospholipids.

Rising concern towards healthy lifestyle and increasing demand of nutritious food and beverage will create growth opportunities. Phospholipid act as emulsifier in the production of processed meat such as salami, sausages and ready to eat meal.

The cosmetic and pharmaceutical manufacturers prefer soy phospholipid for its blending property. Nutraceutical segment is expected to showcase increasing application. According to FMI, over 40% of phospholipids sales will concentrate in this sector.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13040

Key Takeaways from Phospholipids Market Study

Phospholipids market will exhibit string growth at a CAGR of 7.4% between 2021 and 2031
Expansion of pharmaceutical and nutraceutical sectors will support growth in the U.S., enabling it to account for over 78% of North America market
The U.K. market will expand at a steady pace, registering a little above 4% y-o-y growth in 2021
Germany and France will emerge as lucrative markets for phospholipids in Europe
China will account for over half of phospholipids sold in East Asia, followed by Japan and South Korea

“Market players are expected to explore opportunities across diverse industries. Cosmetics industry, for instance, will emerge as a chief end user. The rising demand for ingredients derived from natural sources will fuel phospholipids applications within the sector,” said a lead analyst at FMI.

Application in Diverse Sectors will Drive Sales

Phospholipid is used as an essential ingredient in infant formula. It contains omega-3, omega-6 and fatty acid. It is getting increasingly popular as an ingredient in infant supplementary industry.

The demand of phospholipids is increasing due to its application in different sectors. It is often used as an ingredient in the production of hair conditioner, moisturizer, infant formula, and other products. Phospholipid are widely used in pharmaceutical product such as in oral, dermal, and parenteral products.

https://www.futuremarketinsights.com/checkout/13040

Who is winning?

Some of the key players operating in the phospholipid market are VAV Life Science Pvt. Ltd., Avanti Polar Lipids Inc., ADM, Stern-Wywiol Gruppe, Wilmar International Ltd., Cargill Inc., Lasenor Emul SL, DuPont Inc., Bunge Ltd., SojaProtein a.d., Lipoid Gmbh, Sime Barby Unimills B.V, Kewpie Corporation, Lecico GmnH and many more. Key players are adopting strategies such as new product development, acquisition, and strategic collaborations to gain competitive edge.

For instance, in 2017 Merck made multinational distribution agreement with Avanti Polar Lipids. This agreement includes all worldwide geographies except US, where Avanti will reach consumers through its own channels.
In 2019, Avril has acquired a German company specialized in phospholipid and lecithins, Lecico to expand its product portfolio for nutrition and health business.
In 2017, VAV Life Science has inaugurated it manufacturing facility in Ratnagiri, Maharashtra. The facility is set up in India due to emerging application of phospholipids in pharmaceuticals, functional food, cosmetic and nutritional supplements.
In Jan 2021, Fonterra has launched milk phospholipid in US market. This product is launched with aim of expanding the product portfolio into mental wellness space.

Get Valuable Insights into Phospholipid Market

Product Type

Natural Phospholipids
- Soybean Phospholipids
- Sunflower Phospholipids
- Rapeseed Phospholipids
- Egg Phospholipids
- Others (corn phospholipids and canola phospholipids)
Synthetic Phospholipids

Function

Emulsifiers
Texturizers
Stabilizers
Binding Agent
Releasing Agent

Application

Cosmetics
- Skin Care
- Hair Care
Pharmaceuticals
Nutraceuticals

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Vegan Marshmallows Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2028

The vegan food industry has witnessed spectacular gains in the past few years, owing to increasing realization amongst consumers about the perceived ill-effects on human health as a result of excessive animal based food products. The popularity of plant-based confectionery is an interesting trend in this regard. Bouyed by these factors, Future Market Insights (FMI), in its recently published study, opines that global vegan marshmallows market will grow at over 8% through 2028.

The Vegan Society estimates that demand for plant-based meat alternatives surged by nearly 1000% across the U.K in 2017, while 62% of the population purchased plant-based milk in 2020. Such trends are generating credible expansion possibilities for prominent vegan marshmallow manufacturers.

The surging demand is also attributed to increasing preference for clean label and GMO free foodstuffs. High preference for halal and kosher food items is prompting confectionery giants to offer vegan alternatives.

Key Takeaways

Global vegan marshmallows market to exhibit value CAGR exceeding 8% through 2028
Premium vegan marshmallows to generate over half of the revenue share by 2020-end
Vanilla and peppermint top-selling flavors
Health & wellness stores to register remarkable growth, expanding at a staggering 10.4% CAGR across the forecast period
North America to remain the dominant vegan marshmallows market, surpassing US$ 100 Mn by 2020-end

“Increasing demand for clean-label certifications, including halal and kosher, across prominent regions is motivating vegan food manufacturers to introduce plant-based marshmallows with unique flavor combinations, positively driving market growth,” says the FMI analyst.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12894

COVID-19 Impact Analysis

The novel coronavirus pandemic has ushered in a sea change in consumers’ dietary preferences, with sales of plant-based and vegan foodstuffs spiking across all continents. Growing apprehensions about possible infection contraction through zoonotic channels have compelled consumers to abandon meat consumption and choosing safer alternatives.

This precautionary behavior has also penetrated the marshmallows market, with prominent manufacturers augmenting production of different flavored vegan marshmallows. According to a Veganuary survey, 32% of participants revealed that they were consuming more vegan foods across the UK, US, Latin America and Germany since the pandemic’s outbreak.

Hence, the prospects for vegan marshmallows has been broadening since the past several months. The market is expected to further aggrandize in the upcoming forecast period, with consumers expected to rely largely on clean-label and naturally derived foods way after the pandemic has subsided.

Competitive Landscape

The global vegan marshmallows market is characterized by the presence of various prominent vegan product manufacturers who are effectively leveraging the prevailing clean-label products consumption trends to flood regional markets with innovative flavor combinations.

Some leading players profiled in FMI’s vegan marshmallows market research report include Freedom Confectionery, Chicago Vegan Foods, Mr. Mallo Group, The Naked Marshmallow Co., Ananda Foods Ltd. & The Marshmallowist among others.

Contact Sales for Further Assistance in Purchasing this Report @ https://www.futuremarketinsights.com/checkout/12894

More Insights on FMI’s Vegan Marshmallows Report

Ingredient

Vanilla
Pumpkin
Peppermint
Chocolate
Others

Distribution Channel

Hypermarkets/Supermarkets
Convenience Store
Drug Stores & Pharmacies
Health & Wellness Stores
Online Retailing
Other Retailers

Pricing

Economic
Premium

Region

North America (U.S & Canada)
Latin America (Brazil, Mexico, Argentina & Rest of Latin America)
Europe (EU-4, U.K, BENELUX, Russia, Poland & Rest of Europe)
APEJ (China, India, ASEAN, Australia & New Zealand, South Korea & Rest of APEJ)
Japan
Middle East & Africa (GCC, South Africa & Rest of MEA)

Vegan Supplements Market Gains Impetus from Environmental and Ethical Considerations in Nutraceuticals Sector: FMI

A recent study by Future Market Insights (FMI) opines global vegan supplements market is set to growth at 10.9% CAGR between 2020 and 2028, supported by a growing base of vegan and vegetarian consumers. The rise of the conscientious consumer has led to new opportunities for vegan supplement market players.

Plant-based diets reduce the risks of cancers, coronary disease, diabetes and other lifestyle-based ailments. Also, efforts towards sustainable food production management and ethical consideration in terms of sourcing animal-based ingredients are likely to bolster demand for plant-based product offerings.

As governments set up favorable policies towards plant-based diets, FMI opines bullish prospects for the vegan supplements market.

Key Takeaways

Surge in demand for botanical ingredient sources owing to clean label trends
Online retail distribution channels to gain traction as people look to minimize risks
Demand for vegan supplements in capsule form continues to grow
Europe maintains its position as the most lucrative market globally

“Varied advantages associated with vegan supplements including lower toxicity, superior bioavailability, and natural smell & flavor is expected to bolster the vegan supplements market through the forecast period,” says an FMI analyst.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12896

COVID-19 Impact Analysis

Sales of vegan supplements through online channels has picked up since early 2020, following the outbreak of the coronavirus outbreak. On the other hand, sales from brick-and-mortar outlets have witnessed a moderate drop. OTC offerings are expected to witness higher demand with higher levels of health consciousness driving the demand for immunity-boosting offerings.

This trend is also contributing to increasing adoption of plant-based diets, which will contribute to long term growth in the post pandemic era. Revenue from the vegan supplements market is expected to continue growing as lockdown restrictions are eased, with growing sales coming out of sports nutrition applications.

Who is Winning?

The vegan supplements market is largely competitive and fragmented. Key market players are increasingly focused on product development and launch strategies aimed towards bolstering product portfolios and geographical expansion.

Market leaders include General Mills Inc., Garden of Life, Danone S.A., PepsiCo Inc., Blue Diamond Growers Inc., ALOHA, NuGo Nutrition, One Brands, BHU Foods, and G&G Foods among others.

FitLivings in December 2020 introduced its Okinawa Flat Belly Tonic, which is a non-GMO, vegan friendly, powder-based supplement for consumers in the United States.

HealthyCell a leading dietary supplement company has entered into a partnership with KeHE for the distribution of its Vegan Essentials range of products, which comprises a proprietary gel delivery system.

Contact Sales for Further Assistance in Purchasing this Report @ https://www.futuremarketinsights.com/checkout/12896

More Valuable Insights on Vegan Supplements Market

Product Type

Powder
Liquid
Capsules
Bars
Others

Ingredients

Vitamins & Minerals
Amino Acids
Botanical Supplements
Others

Distribution Channel

Hypermarkets/Supermarkets
Convenience Stores
Drug Stores & Pharmacies
Health & Wellness Stores
Online Retailing
Others

Region

North America (U.S. & Canada)
Latin America (Mexico, Brazil, & Rest of LATAM)
Europe (Germany, U.K., France, Italy, Spain, BENELUX, Russia, & Rest of Europe)
Middle East and Africa (GCC Countries, South Africa & Rest of MEA)
Japan
Asia Pacific excluding Japan (China, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand & Rest of APEJ)

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Clean Label Pectin Market Huge Growth Opportunity between 2021-2031

Clean label pectin is used as a primary ingredient in various food applications such as jams, jellies, sauces, fruits spreads, chews, bakery fillings, juices, toppings, sugar confectionery, fermented dairy products, and plant based products. Driven by the increasing application as stabilizer, the clean label pectin market is forecast to rise at nearly 7% CAGR between 2021 and 2031. Future Market Insights (FMI) presents a positive outlook for the market in its study as focus on healthy eating continues to rise around the world.

Consumers in general have become more curious about the source of the raw material and production methods used for processing various food products. A few of the production methods are observed as less ‘natural’ while some food ingredients are considered as ‘unhealthy’ and ‘unfamiliar’.

The ‘clean label’ trend is expected to have considerable influence on the food industry especially since consumers have become more interested in ingredients used in their food. There is clear inclination for more ‘natural’ methods of production using ingredients derived from organic or natural sources. According to FMI, citrus fruits are highly sought-after sources of clean label pectin. In fact, citrus fruits made for over 43% of clean label pectin produced in 2020.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12899

Key Takeaways from Clean Label Pectin Market Report

Clean label pectin market will exhibit 5.8% y-o-y growth in 2021, registering 0.3% improvement than growth recorded last year
Increasing focus on healthy eating seals America’s dominance. The U.S. to account for a little below 85% of sales recorded in North America
U.K. emerges as a key market within Europe, exhibiting over 8% y-o-y growth in 2021
Rising focus on health and wellness to continue driving sales in Germany and France
While China will continue dominating sales in East Asia, both Japan and South Korea are forecast to register higher rate of growth

“Consumers are likelier to check ingredients list on a food product to ascertain if it is sustainable and environment-friendly. Smaller manufacturers see this as a lucrative opportunity to establish their brand presence in a highly competitive landscape. With focus on end-to-end clarity rising, more companies are jumping into the clean-label bandwagon, irrespective of their size. Spurred by this, clean label pectin producers will gain from increasing application within the food industry,” said a lead analyst at FMI.

Contact Sales for Further Assistance in Purchasing this Report @ https://www.futuremarketinsights.com/checkout/12899

Demand from Pharmaceutical Industry Poised to Surge

Clean label pectin market is anticipated to register increasing demand from the pharmaceutical industry. Gelling property of clean label pectin has been increasing its use in making gel beads, film coated dosage, and matrix tablets. Clean label pectin is mainly used for medicine for diarrhea, throat lozenges and constipation. It also is used in nutritional and health products which help in weight loss, strengthens skin and hair, enhance iron absorption, and improve heart health.

Increasing Demand for Organic and Clean Label Food Will Accelerate Sales

Consumers are shifting towards healthy, high vitamin, nutrient rich food and avoiding foods with artificial flavour, colour, GMO levels and preservatives. Increasing health awareness and high demand for low sugar fruit products will drive the clean label pectin market. Consumer inclination toward natural and organic food is persistent rising due to rising health consciousness and it is accelerating the growth of clean label pectin. Due to rising demand for organic and clean label products, key players of clean label pectin market are focusing on launching unique clean label pectin products in the market.

For instance,

In 2020 CP Kelco introduced GENU Pectin YM-FP-2100, a clean label ingredient that provides a medium-to-high viscosity in the fruit drinking yogurt and with ease of pump ability at the fruit prep stage.
In 2018, DuPont Nutrition & Health launched and developed GRINDSTED Pectin PRIME 541, product which allow food producer to make new tempting reduced-sugar fruit spread and without processing hurdles.

Who is Winning?

Some of the key players operating in the clean label pectin market are CP Kelco, Cargill, Inc, Herbstreith & Fox, Royal DSM, DuPont Nutrition & Health, Brenntag North America, Inc., Silvateam Food Ingredients, Lucid Colloids Ltd. and many more. In order to gain competitive advantage, market players have been focusing on expansion via merger and acquisition strategies. Besides this, product launches are undertaken to strengthen their footprint.

For instance,

In 2020 Herbstreith & Fox (H&F Group), a producer of pectin base in Germany acquired pectin buisness from Givaudan SA (Switzerland) part of the Naturex portfolio.
In 2018, Brenntag North America Inc. entered into partnership with Silvateam for the extensive distribution of pectin in the Canada and United States.
In 2019, CP Kelco launched a new product line, NUTRAVA citrus fiber it is a clean label ingredient which is derived from peels of citrus fruits.

Get Valuable Insights into Clean Label Pectin Market

By Product type

High methoxyl
Low methoxyl
- Amidated (LMA)
- Non-amidated

By source

Citrus food
- Orange
- Lemon & lime
- Tangrient and mandarins
- Grapefruit
Apple
Pear
Plum
Banana
Others (Berries)

By end use application

Fermented Plant based products
Fermented dairy products, including yoghurt
Jams
Jellies
Chews
Fruit Spreads
Sugar Confectionary
Fruit roll ups
Fruit Preparations
Bakery Fillings
Glazes
Sauces
Toppings
Ripples
Compotes
Juices
Reduced- Sugar beverages

By Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)